The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Hydroxyprogesterone Caproate Injection Market Research Report 2024
Synopsis
Hydroxyprogesterone caproate (OHPC), sold under the brand names Proluton and Makena among others, is a progestin medication which is used to prevent preterm birth in pregnant women with a history of the condition and to treat gynecological disorders.It has also been formulated in combination with estrogens for various indications (brand names Gravibinon and Primosiston) and as a form of long-lasting injectable birth control (brand name Chinese Injectable No. 1). It is not used by mouth and is instead given by injection into muscle or fat, typically once per week to once per month depending on the indication.
The global Hydroxyprogesterone Caproate Injection market was valued at US$ 263 million in 2023 and is anticipated to reach US$ 292.3 million by 2030, witnessing a CAGR of 1.5% during the forecast period 2024-2030.
Global hydroxyprogesterone caproate injection main manufactuers include AMAG Pharmaceuticals, Mcguff Pharmaceuticals and Aspen, etc., totally holding a share for 97% of the market. North America is the largest market of hydroxyprogesterone caproate injection, with a share about 37%. As for the types of products, it can be divided into 1 ml injection(including 1.1 mL) and 5 ml injection. The most common product is 5 ml injection, with a share over 52%. In terms of applications, it is widely used in hospitals and clinics. The most commom application is in hospitals, with a share over 50%.
This report aims to provide a comprehensive presentation of the global market for Hydroxyprogesterone Caproate Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hydroxyprogesterone Caproate Injection.
Report Scope
The Hydroxyprogesterone Caproate Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hydroxyprogesterone Caproate Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hydroxyprogesterone Caproate Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AMAG Pharmaceuticals
Mcguff Pharmaceuticals Inc
Aspen Oss B.V
American Regent, Inc.
Mylan Institutional
Segment by Type
1 mL Injection(Including 1.1 mL)
5 mL Injection
Segment by Application
Hospitals Injection
Clinics Injection
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hydroxyprogesterone Caproate Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hydroxyprogesterone Caproate Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Hydroxyprogesterone caproate (OHPC), sold under the brand names Proluton and Makena among others, is a progestin medication which is used to prevent preterm birth in pregnant women with a history of the condition and to treat gynecological disorders.It has also been formulated in combination with estrogens for various indications (brand names Gravibinon and Primosiston) and as a form of long-lasting injectable birth control (brand name Chinese Injectable No. 1). It is not used by mouth and is instead given by injection into muscle or fat, typically once per week to once per month depending on the indication.
The global Hydroxyprogesterone Caproate Injection market was valued at US$ 263 million in 2023 and is anticipated to reach US$ 292.3 million by 2030, witnessing a CAGR of 1.5% during the forecast period 2024-2030.
Global hydroxyprogesterone caproate injection main manufactuers include AMAG Pharmaceuticals, Mcguff Pharmaceuticals and Aspen, etc., totally holding a share for 97% of the market. North America is the largest market of hydroxyprogesterone caproate injection, with a share about 37%. As for the types of products, it can be divided into 1 ml injection(including 1.1 mL) and 5 ml injection. The most common product is 5 ml injection, with a share over 52%. In terms of applications, it is widely used in hospitals and clinics. The most commom application is in hospitals, with a share over 50%.
This report aims to provide a comprehensive presentation of the global market for Hydroxyprogesterone Caproate Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hydroxyprogesterone Caproate Injection.
Report Scope
The Hydroxyprogesterone Caproate Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hydroxyprogesterone Caproate Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hydroxyprogesterone Caproate Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AMAG Pharmaceuticals
Mcguff Pharmaceuticals Inc
Aspen Oss B.V
American Regent, Inc.
Mylan Institutional
Segment by Type
1 mL Injection(Including 1.1 mL)
5 mL Injection
Segment by Application
Hospitals Injection
Clinics Injection
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hydroxyprogesterone Caproate Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hydroxyprogesterone Caproate Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Hydroxyprogesterone Caproate Injection Market Overview
1.1 Product Overview and Scope of Hydroxyprogesterone Caproate Injection
1.2 Hydroxyprogesterone Caproate Injection Segment by Type
1.2.1 Global Hydroxyprogesterone Caproate Injection Market Value Comparison by Type (2024-2030)
1.2.2 1 mL Injection(Including 1.1 mL)
1.2.3 5 mL Injection
1.3 Hydroxyprogesterone Caproate Injection Segment by Application
1.3.1 Global Hydroxyprogesterone Caproate Injection Market Value by Application: (2024-2030)
1.3.2 Hospitals Injection
1.3.3 Clinics Injection
1.4 Global Hydroxyprogesterone Caproate Injection Market Size Estimates and Forecasts
1.4.1 Global Hydroxyprogesterone Caproate Injection Revenue 2019-2030
1.4.2 Global Hydroxyprogesterone Caproate Injection Sales 2019-2030
1.4.3 Global Hydroxyprogesterone Caproate Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Hydroxyprogesterone Caproate Injection Market Competition by Manufacturers
2.1 Global Hydroxyprogesterone Caproate Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Hydroxyprogesterone Caproate Injection Average Price by Manufacturers (2019-2024)
2.4 Global Hydroxyprogesterone Caproate Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hydroxyprogesterone Caproate Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hydroxyprogesterone Caproate Injection, Product Type & Application
2.7 Hydroxyprogesterone Caproate Injection Market Competitive Situation and Trends
2.7.1 Hydroxyprogesterone Caproate Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hydroxyprogesterone Caproate Injection Players Market Share by Revenue
2.7.3 Global Hydroxyprogesterone Caproate Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hydroxyprogesterone Caproate Injection Retrospective Market Scenario by Region
3.1 Global Hydroxyprogesterone Caproate Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Hydroxyprogesterone Caproate Injection Global Hydroxyprogesterone Caproate Injection Sales by Region: 2019-2030
3.2.1 Global Hydroxyprogesterone Caproate Injection Sales by Region: 2019-2024
3.2.2 Global Hydroxyprogesterone Caproate Injection Sales by Region: 2025-2030
3.3 Global Hydroxyprogesterone Caproate Injection Global Hydroxyprogesterone Caproate Injection Revenue by Region: 2019-2030
3.3.1 Global Hydroxyprogesterone Caproate Injection Revenue by Region: 2019-2024
3.3.2 Global Hydroxyprogesterone Caproate Injection Revenue by Region: 2025-2030
3.4 North America Hydroxyprogesterone Caproate Injection Market Facts & Figures by Country
3.4.1 North America Hydroxyprogesterone Caproate Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Hydroxyprogesterone Caproate Injection Sales by Country (2019-2030)
3.4.3 North America Hydroxyprogesterone Caproate Injection Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hydroxyprogesterone Caproate Injection Market Facts & Figures by Country
3.5.1 Europe Hydroxyprogesterone Caproate Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Hydroxyprogesterone Caproate Injection Sales by Country (2019-2030)
3.5.3 Europe Hydroxyprogesterone Caproate Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hydroxyprogesterone Caproate Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Hydroxyprogesterone Caproate Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Hydroxyprogesterone Caproate Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Hydroxyprogesterone Caproate Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Hydroxyprogesterone Caproate Injection Market Facts & Figures by Country
3.7.1 Latin America Hydroxyprogesterone Caproate Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Hydroxyprogesterone Caproate Injection Sales by Country (2019-2030)
3.7.3 Latin America Hydroxyprogesterone Caproate Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hydroxyprogesterone Caproate Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Hydroxyprogesterone Caproate Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Hydroxyprogesterone Caproate Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Hydroxyprogesterone Caproate Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hydroxyprogesterone Caproate Injection Sales by Type (2019-2030)
4.1.1 Global Hydroxyprogesterone Caproate Injection Sales by Type (2019-2024)
4.1.2 Global Hydroxyprogesterone Caproate Injection Sales by Type (2025-2030)
4.1.3 Global Hydroxyprogesterone Caproate Injection Sales Market Share by Type (2019-2030)
4.2 Global Hydroxyprogesterone Caproate Injection Revenue by Type (2019-2030)
4.2.1 Global Hydroxyprogesterone Caproate Injection Revenue by Type (2019-2024)
4.2.2 Global Hydroxyprogesterone Caproate Injection Revenue by Type (2025-2030)
4.2.3 Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Type (2019-2030)
4.3 Global Hydroxyprogesterone Caproate Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Hydroxyprogesterone Caproate Injection Sales by Application (2019-2030)
5.1.1 Global Hydroxyprogesterone Caproate Injection Sales by Application (2019-2024)
5.1.2 Global Hydroxyprogesterone Caproate Injection Sales by Application (2025-2030)
5.1.3 Global Hydroxyprogesterone Caproate Injection Sales Market Share by Application (2019-2030)
5.2 Global Hydroxyprogesterone Caproate Injection Revenue by Application (2019-2030)
5.2.1 Global Hydroxyprogesterone Caproate Injection Revenue by Application (2019-2024)
5.2.2 Global Hydroxyprogesterone Caproate Injection Revenue by Application (2025-2030)
5.2.3 Global Hydroxyprogesterone Caproate Injection Revenue Market Share by Application (2019-2030)
5.3 Global Hydroxyprogesterone Caproate Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AMAG Pharmaceuticals
6.1.1 AMAG Pharmaceuticals Corporation Information
6.1.2 AMAG Pharmaceuticals Description and Business Overview
6.1.3 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AMAG Pharmaceuticals Hydroxyprogesterone Caproate Injection Product Portfolio
6.1.5 AMAG Pharmaceuticals Recent Developments/Updates
6.2 Mcguff Pharmaceuticals Inc
6.2.1 Mcguff Pharmaceuticals Inc Corporation Information
6.2.2 Mcguff Pharmaceuticals Inc Description and Business Overview
6.2.3 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Mcguff Pharmaceuticals Inc Hydroxyprogesterone Caproate Injection Product Portfolio
6.2.5 Mcguff Pharmaceuticals Inc Recent Developments/Updates
6.3 Aspen Oss B.V
6.3.1 Aspen Oss B.V Corporation Information
6.3.2 Aspen Oss B.V Description and Business Overview
6.3.3 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Aspen Oss B.V Hydroxyprogesterone Caproate Injection Product Portfolio
6.3.5 Aspen Oss B.V Recent Developments/Updates
6.4 American Regent, Inc.
6.4.1 American Regent, Inc. Corporation Information
6.4.2 American Regent, Inc. Description and Business Overview
6.4.3 American Regent, Inc. Hydroxyprogesterone Caproate Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 American Regent, Inc. Hydroxyprogesterone Caproate Injection Product Portfolio
6.4.5 American Regent, Inc. Recent Developments/Updates
6.5 Mylan Institutional
6.5.1 Mylan Institutional Corporation Information
6.5.2 Mylan Institutional Description and Business Overview
6.5.3 Mylan Institutional Hydroxyprogesterone Caproate Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Mylan Institutional Hydroxyprogesterone Caproate Injection Product Portfolio
6.5.5 Mylan Institutional Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hydroxyprogesterone Caproate Injection Industry Chain Analysis
7.2 Hydroxyprogesterone Caproate Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hydroxyprogesterone Caproate Injection Production Mode & Process
7.4 Hydroxyprogesterone Caproate Injection Sales and Marketing
7.4.1 Hydroxyprogesterone Caproate Injection Sales Channels
7.4.2 Hydroxyprogesterone Caproate Injection Distributors
7.5 Hydroxyprogesterone Caproate Injection Customers
8 Hydroxyprogesterone Caproate Injection Market Dynamics
8.1 Hydroxyprogesterone Caproate Injection Industry Trends
8.2 Hydroxyprogesterone Caproate Injection Market Drivers
8.3 Hydroxyprogesterone Caproate Injection Market Challenges
8.4 Hydroxyprogesterone Caproate Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
